Go Deep
Fischer Medical Ventures Limited
Fischer Medical Ventures Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 26,757 | 73.2 | 5.53 | 0.28 | 32.95 |
| Sep 2026 | 26,556 | 71.7 | 5.78 | 0.28 | 34.40 |
| Sep 2026 | 26,377 | 75.7 | 6.07 | 0.28 | 34.08 |
| Sep 2026 | 26,377 | 75.7 | 6.07 | 0.28 | 34.08 |
| Sep 2026 | 26,377 | 75.7 | 6.07 | 0.28 | 34.08 |
| Sep 2026 | 26,377 | 75.7 | 6.07 | 0.28 | 34.08 |
| Oct 2026 | 25,035 | 74.4 | 5.96 | 0.28 | 33.46 |
| Oct 2026 | 23,987 | 13.0 | 5.52 | 0.28 | 30.37 |
Fischer Medical Ventures Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 819,200,000.0 | 977,304,000.0 | 1,010,952,000.0 | 234,447,000.0 |
| Net Profit | 37,913,000.0 | -71,194,000.0 | 192,348,000.0 | 48,601,000.0 |
| EPS | 0.1 | -0.1 | 0.3 | 0.1 |
Fischer Medical Ventures Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 3,085,756,000.0 | 1,106,987,000.0 | 209,813,000.0 | 1,795,000.0 | — |
| Net Profit | 322,098,000.0 | 14,819,000.0 | 18,379,000.0 | -365,000.0 | — |
| EPS | 0.5 | 0.0 | 1.6 | -2.1 | — |
Fischer Medical Ventures Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 6,710,105,000.0 | 4,573,704,000.0 | 863,217,000.0 | 3,535,000.0 | — |
| Total Liabilities | 2,858,683,000.0 | 1,195,227,000.0 | 52,072,000.0 | 6,195,000.0 | — |
| Total Equity | 3,843,394,000.0 | 3,677,271,000.0 | 811,145,000.0 | -2,660,000.0 | — |
Owes vs Owns
Fischer Medical Ventures Limited owed ₹0.43 for every ₹1 it owned in Mar 2026, down from ₹1.75 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.43× | 0.26× | 0.06× | 1.75× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Fischer Medical Ventures Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 3.7%Receivables 43.0%Inventory 1.9%Fixed assets (tangible) 11.5%Intangible assets 0.8%Long-term investments 17.5%Other assets 21.6%
How it's funded — Mar 2026
Short-term debt 10.7%Payables 15.3%Other liabilities 16.5%Shareholders' equity 57.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 25.0 | 275.3 | 37.9 | 0.0 |
| Receivables | 288.8 | 76.1 | 22.9 | 0.2 |
| Inventory | 12.7 | 9.2 | 4.5 | 0.0 |
| Fixed assets (tangible) | 76.9 | 40.0 | 12.5 | 0.0 |
| Intangible assets | 5.3 | 5.3 | 2.2 | 0.0 |
| Long-term investments | 117.7 | 10.4 | 0.0 | 0.0 |
| Other assets | 144.6 | 41.2 | 6.3 | 0.1 |
| Liabilities & equity | ||||
| Short-term debt | 72.1 | 40.7 | 0.0 | 0.6 |
| Long-term debt | 0.3 | 19.7 | 0.0 | 0.6 |
| Payables | 102.6 | 20.7 | 2.2 | 0.0 |
| Other liabilities | 110.9 | 38.5 | 3.1 | 0.0 |
| Shareholders' equity | 385.1 | 337.8 | 81.1 | -0.3 |
| Net tangible assets | 379.1 | 362.5 | 78.9 | -0.3 |
Fischer Medical Ventures Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -1,012,665,000.0 | -862,518,000.0 | -73,520,000.0 | -1,459,000.0 | — |
| Investing Activities | -52,169,000.0 | -1,253,631,000.0 | -313,857,000.0 | 0.0 | — |
| Financing Activities | 141,100,000.0 | 3,149,244,000.0 | 370,572,000.0 | 1,660,000.0 | — |